| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.31e-04 | 152 | 196 | 8 | GO:0016779 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8K1 OR5T1 PDGFRA OR13F1 OR2B6 IL1RL2 OR51J1 CHRNB2 GPR146 OR2K2 OR4C3 PTPRD CD300LB CMKLR1 PLXNA1 GPR151 OR8J3 OR4K2 OR8K5 OR8J1 CR1 GRM7 VN1R1 TAS1R1 OR4C46 EPHA10 HCRTR1 OR2A2 | 1.44e-04 | 1353 | 196 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.67e-04 | 83 | 196 | 6 | GO:0015101 | |
| GeneOntologyMolecularFunction | DNA-directed 5'-3' RNA polymerase activity | 2.02e-04 | 30 | 196 | 4 | GO:0003899 | |
| GeneOntologyMolecularFunction | 5'-3' RNA polymerase activity | 2.61e-04 | 32 | 196 | 4 | GO:0034062 | |
| GeneOntologyMolecularFunction | RNA polymerase activity | 2.61e-04 | 32 | 196 | 4 | GO:0097747 | |
| GeneOntologyMolecularFunction | L-isoleucine transmembrane transporter activity | 2.86e-04 | 3 | 196 | 2 | GO:0015188 | |
| GeneOntologyMolecularFunction | ribonucleoside binding | 2.86e-04 | 3 | 196 | 2 | GO:0032549 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8K1 OR5T1 OR13F1 OR2B6 OR51J1 OR2K2 OR4C3 OR8J3 OR4K2 OR8K5 OR8J1 OR4C46 OR2A2 | 3.50e-04 | 431 | 196 | 13 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8K1 OR5T1 OR13F1 OR2B6 OR51J1 GPR146 OR2K2 OR4C3 CMKLR1 GPR151 OR8J3 OR4K2 OR8K5 OR8J1 GRM7 VN1R1 TAS1R1 OR4C46 HCRTR1 OR2A2 | 4.55e-04 | 884 | 196 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | CDKAL1 POLR1B ASCC3 FTO TARBP1 REV1 MED20 DHX58 POLE SLFN12 PIWIL2 POLR3C POLR3B DROSHA NEIL3 PAN3 | 6.52e-04 | 645 | 196 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLCO2B1 SLC6A17 SLC5A7 SLC35E1 SLC26A5 SLC6A3 SLC44A1 SLCO1A2 SLC6A20 SLC13A5 | 7.14e-04 | 296 | 196 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | CDKAL1 POLR1B FTO TARBP1 MED20 DHX58 SLFN12 PIWIL2 POLR3C POLR3B DROSHA PAN3 | 8.88e-04 | 417 | 196 | 12 | GO:0140098 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCB7 ABCA12 SLCO2B1 SLC6A17 SLC5A7 SLC35E1 ABCA8 SLC26A5 SLC6A3 SLC44A1 SLCO1A2 SLC6A20 SLC13A5 | 9.00e-04 | 477 | 196 | 13 | GO:0022804 |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 9.40e-04 | 5 | 196 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | HK1 PDGFRA RPS6KA1 MAP3K3 ADK GRK3 PIP4K2A BUB1 DLG1 POLR1B GMPPB REV1 MED20 POLE PARP2 POLR3C POLR3B ATM PAN3 EPHA10 | 9.49e-04 | 938 | 196 | 20 | GO:0016772 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8K1 OR5T1 OR13F1 BBS4 OR2B6 OR51J1 OR2K2 OR4C3 PLCB2 OR8J3 OR4K2 OR8K5 OR8J1 VN1R1 SLC6A3 TAS1R1 OR4C46 OR2A2 | 4.80e-06 | 547 | 195 | 18 | GO:0007606 |
| GeneOntologyBiologicalProcess | GDP-mannose biosynthetic process from glucose | 8.21e-06 | 5 | 195 | 3 | GO:0141199 | |
| GeneOntologyBiologicalProcess | sensory perception | OR8K1 OR5T1 OR13F1 BBS4 OR2B6 OR51J1 CHRNB2 OR2K2 OR4C3 PLCB2 FTO CACNA1F OR8J3 OR4K2 SLC26A5 OR8K5 OPA3 OR8J1 GRM7 VN1R1 SLC6A3 ATF6 TAS1R1 OR4C46 CRYBG3 OR2A2 | 9.90e-06 | 1072 | 195 | 26 | GO:0007600 |
| GeneOntologyBiologicalProcess | GDP-mannose biosynthetic process | 2.83e-05 | 7 | 195 | 3 | GO:0009298 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8K1 OR5T1 OR13F1 BBS4 OR2B6 OR51J1 OR2K2 OR4C3 OR8J3 OR4K2 OR8K5 OR8J1 SLC6A3 OR4C46 OR2A2 | 3.83e-05 | 465 | 195 | 15 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8K1 OR5T1 OR13F1 OR2B6 OR51J1 OR2K2 OR4C3 PLCB2 OR8J3 OR4K2 OR8K5 OR8J1 TAS1R1 OR4C46 OR2A2 | 6.17e-05 | 485 | 195 | 15 | GO:0050907 |
| Domain | ARM-type_fold | RALGAPA1 USP34 ELMO1 DOCK5 UTP20 TAF2 TARBP1 USP24 RIF1 CSE1L ATM WDFY3 | 2.20e-04 | 339 | 193 | 12 | IPR016024 |
| Domain | - | 3.17e-04 | 3 | 193 | 2 | 2.40.270.10 | |
| Domain | RNA_pol_RPB2_OB-fold | 3.17e-04 | 3 | 193 | 2 | IPR014724 | |
| Domain | RNA_pol_bsu_CS | 3.17e-04 | 3 | 193 | 2 | IPR007121 | |
| Domain | DNA-dir_RNA_pol_su2_6 | 3.17e-04 | 3 | 193 | 2 | IPR007120 | |
| Domain | RNA_pol_Rpb2_7 | 3.17e-04 | 3 | 193 | 2 | PF04560 | |
| Domain | RNA_pol_Rpb2_2 | 3.17e-04 | 3 | 193 | 2 | PF04561 | |
| Domain | RNA_pol_Rpb2_5 | 3.17e-04 | 3 | 193 | 2 | PF04567 | |
| Domain | RNA_pol_Rpb2_1 | 3.17e-04 | 3 | 193 | 2 | PF04563 | |
| Domain | RNA_pol_Rpb2_3 | 3.17e-04 | 3 | 193 | 2 | PF04565 | |
| Domain | RNA_pol_Rpb2_5 | 3.17e-04 | 3 | 193 | 2 | IPR007647 | |
| Domain | RNA_pol_Rpb2_3 | 3.17e-04 | 3 | 193 | 2 | IPR007645 | |
| Domain | RNA_pol_bsu_protrusion | 3.17e-04 | 3 | 193 | 2 | IPR007644 | |
| Domain | RNA_pol_Rpb2_2 | 3.17e-04 | 3 | 193 | 2 | IPR007642 | |
| Domain | RNA_pol_Rpb2_7 | 3.17e-04 | 3 | 193 | 2 | IPR007641 | |
| Domain | - | 3.17e-04 | 3 | 193 | 2 | 2.40.50.150 | |
| Domain | RNA_POL_BETA | 3.17e-04 | 3 | 193 | 2 | PS01166 | |
| Domain | - | 3.17e-04 | 3 | 193 | 2 | 3.90.1110.10 | |
| Domain | DNA-dir_RNA_pol_su2 | 3.17e-04 | 3 | 193 | 2 | IPR015712 | |
| Domain | RNA_pol_Rpb2_6 | 3.17e-04 | 3 | 193 | 2 | PF00562 | |
| Domain | GPCR_Rhodpsn_7TM | OR8K1 OR5T1 OR13F1 OR2B6 GPR146 OR2K2 OR4C3 CMKLR1 GPR151 OR8J3 OR4K2 OR8K5 OR8J1 VN1R1 OR4C46 HCRTR1 OR2A2 | 6.07e-04 | 670 | 193 | 17 | IPR017452 |
| Domain | Sec63 | 6.29e-04 | 4 | 193 | 2 | PF02889 | |
| Domain | Sec63 | 6.29e-04 | 4 | 193 | 2 | SM00973 | |
| Domain | Sec63-dom | 6.29e-04 | 4 | 193 | 2 | IPR004179 | |
| Domain | AAA | 7.53e-04 | 144 | 193 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 7.53e-04 | 144 | 193 | 7 | IPR003593 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8K1 OR5T1 OR13F1 OR2B6 GPR146 OR2K2 OR4C3 CMKLR1 GPR151 OR8J3 OR4K2 OR8K5 OR8J1 VN1R1 OR4C46 HCRTR1 OR2A2 | 7.76e-04 | 685 | 193 | 17 | PS00237 |
| Domain | NA_NEUROTRAN_SYMP_2 | 7.91e-04 | 18 | 193 | 3 | PS00754 | |
| Domain | Olfact_rcpt | OR8K1 OR5T1 OR13F1 OR2B6 OR2K2 OR4C3 OR8J3 OR4K2 OR8K5 OR8J1 OR4C46 OR2A2 | 8.24e-04 | 393 | 193 | 12 | IPR000725 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8K1 OR5T1 OR13F1 OR2B6 GPR146 OR2K2 OR4C3 CMKLR1 GPR151 OR8J3 OR4K2 OR8K5 OR8J1 VN1R1 OR4C46 HCRTR1 OR2A2 | 8.54e-04 | 691 | 193 | 17 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8K1 OR5T1 OR13F1 OR2B6 GPR146 OR2K2 OR4C3 CMKLR1 GPR151 OR8J3 OR4K2 OR8K5 OR8J1 VN1R1 OR4C46 HCRTR1 OR2A2 | 8.68e-04 | 692 | 193 | 17 | IPR000276 |
| Domain | SNF | 9.32e-04 | 19 | 193 | 3 | PF00209 | |
| Domain | Na/ntran_symport | 9.32e-04 | 19 | 193 | 3 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 9.32e-04 | 19 | 193 | 3 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 9.32e-04 | 19 | 193 | 3 | PS50267 | |
| Domain | Na/ntran_symport_orphan | 1.04e-03 | 5 | 193 | 2 | IPR002438 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ABCB7 HK1 SLC35E1 SPART TRAPPC1 CDKAL1 KLHL9 FDFT1 GLUL RBM14 POLR1B ASCC3 GMPPB HSPA9 SPTLC2 POLE DTL TPGS2 ATF6 RIF1 PDIA6 CSE1L SNRPA SNRPB2 RPL7 HDAC1 | 1.50e-08 | 1257 | 198 | 26 | 37317656 |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8K1 OR5T1 OR13F1 OR2B6 OR51J1 OR2K2 OR4C3 OR8J3 OR4K2 OR8K5 OR8J1 OR4C46 OR2A2 | 9.04e-08 | 340 | 198 | 13 | 11875048 |
| Pubmed | OR8K1 OR5T1 OR13F1 OR2B6 OR51J1 OR2K2 OR4C3 OR8J3 OR4K2 OR8K5 OR8J1 OR4C46 OR2A2 | 9.04e-08 | 340 | 198 | 13 | 11802173 | |
| Pubmed | OR8K1 OR5T1 OR13F1 OR2B6 OR51J1 OR2K2 OR4C3 OR8J3 OR4K2 OR8K5 OR8J1 OR4C46 OR2A2 | 1.00e-07 | 343 | 198 | 13 | 32295537 | |
| Pubmed | OR8K1 OR5T1 OR13F1 OR2B6 OR51J1 OR2K2 OR4C3 OR8J3 OR4K2 OR8K5 OR8J1 OR4C46 OR2A2 | 1.11e-07 | 346 | 198 | 13 | 14611657 | |
| Pubmed | RALGAPA1 SPART CDKAL1 DLG1 ASCC3 SNX9 HSPA9 CARMIL1 USP24 SHTN1 PDIA6 CSE1L CRYBG3 OCLN SEC63 RPL7 HDAC1 | 7.36e-07 | 708 | 198 | 17 | 39231216 | |
| Pubmed | RALGAPA1 USP34 SLC35E1 GPR108 CDKAL1 KLHL9 GLE1 ZNF638 DLG1 POLR1B TASOR DTL P3H4 STRIP1 MAPRE1 POLR3B SEC63 | 1.18e-06 | 733 | 198 | 17 | 34672954 | |
| Pubmed | USP34 HIVEP2 ENPP2 TRAPPC1 HSPA13 CYRIA PTPRD GLUL DLG1 PLCG1 TARBP1 HSPA9 BRWD1 USP28 HECTD4 SHTN1 ATF6 POLR3B DROSHA ATM WDFY3 PC | 4.68e-06 | 1285 | 198 | 22 | 35914814 | |
| Pubmed | DENND4A THNSL1 RPS6KA1 SLC35E1 DOCK5 BUB1 RBM14 ZNF638 DLG1 TASOR ARHGEF28 POLE PDIA6 DROSHA CRYBG3 | 5.44e-06 | 650 | 198 | 15 | 38777146 | |
| Pubmed | ADAD1 GLE1 RBM14 ZNF638 POLR1B BRWD1 PIWIL2 ADAM5 ELAVL2 SNRPA SNRPB2 | 5.49e-06 | 347 | 198 | 11 | 16033648 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DENND4A SLC35E1 BBS4 NME8 TRAPPC1 MAP3K3 DOCK5 ARHGAP44 BUB1 RBM14 ZNF638 SNX9 RSPH9 GPI CARMIL1 RFX3 MAPRE1 RIF1 CSE1L PAN3 SNRPB2 HDAC1 | 7.23e-06 | 1321 | 198 | 22 | 27173435 |
| Pubmed | USP34 ABCB7 HK1 SLC35E1 TRAPPC1 CDKAL1 EVI5 FDFT1 RBM14 ASCC3 SNX9 DHX58 SPTLC2 ST7 PARP2 VPS8 GOSR2 PDIA6 POLR3B CSE1L OXCT1 ATM SEC63 | 8.69e-06 | 1440 | 198 | 23 | 30833792 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK1 PIP4K2A RBM14 ZNF638 UTP20 POLR1B PLCG1 TAF2 ASCC3 GMPPB HSPA9 GPI SPTLC2 POLE RIF1 PDIA6 POLR3B CSE1L OXCT1 WDFY3 SNRPA RPL7 | 1.05e-05 | 1353 | 198 | 22 | 29467282 |
| Pubmed | USP34 HK1 DOCK5 RBM14 ZNF638 DLG1 TASOR HSPA9 GPI MUC16 STRIP1 MAPRE1 RIF1 OCLN PC RPL7 | 1.09e-05 | 777 | 198 | 16 | 35844135 | |
| Pubmed | USP34 HIVEP2 PTPRD HSPA9 GPR151 CACNA1B USP28 SLC6A3 PDIA6 CSE1L | 1.76e-05 | 322 | 198 | 10 | 26514267 | |
| Pubmed | 1.87e-05 | 28 | 198 | 4 | 20534741 | ||
| Pubmed | Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations. | 2.12e-05 | 10 | 198 | 3 | 22344221 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 2.12e-05 | 262 | 198 | 9 | 36880596 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DENND4A HK1 ACOT13 GLUL RBM14 UTP20 PLCG1 HSPA9 PLXNA1 GPI POLE MAPRE1 RIF1 PDIA6 CSE1L ATM SEC63 SNRPA PC SNRPB2 RPL7 HDAC1 | 2.32e-05 | 1425 | 198 | 22 | 30948266 |
| Pubmed | USP34 SPAM1 ACTR5 ABCA12 GPR108 ABCA8 CDKAL1 ZNF608 PIP4K2A TAF2 ASCC3 BRWD1 AOX1 PRDM5 P3H4 DROSHA WDFY3 CRYBG3 HDAC1 | 2.33e-05 | 1116 | 198 | 19 | 31753913 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PLBD1 SLCO2B1 SLC5A7 ELMO1 CDKAL1 EVI5 PTPRD GLE1 FDFT1 RBM14 CLDN34 FTO MAN2B2 CARMIL1 USP24 SLC35F1 TEAD3 STARD6 HDAC1 UEVLD | 3.10e-05 | 1242 | 198 | 20 | 30973865 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | SLC35E1 CDKAL1 GLE1 FDFT1 UTP20 ASCC3 SNX9 TARBP1 SPTLC2 POLE DTL USP24 ATF6 PDIA6 CSE1L OCLN SEC63 | 3.10e-05 | 942 | 198 | 17 | 31073040 |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 25132355 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 34400226 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 36628934 | ||
| Pubmed | FTO affects hippocampal function by regulation of BDNF processing. | 3.22e-05 | 2 | 198 | 2 | 30730976 | |
| Pubmed | FTO predicts weight regain in the Look AHEAD clinical trial. | 3.22e-05 | 2 | 198 | 2 | 23628854 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 10531300 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 20231358 | ||
| Pubmed | Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice. | 3.22e-05 | 2 | 198 | 2 | 37043976 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 28968864 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 23817550 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 19932884 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 25637490 | ||
| Pubmed | Mannose efflux from the cells: a potential source of mannose in blood. | 3.22e-05 | 2 | 198 | 2 | 21273394 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 31586043 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 31189104 | ||
| Pubmed | The Effects of N-Glycosylation on the Expression and Transport Activity of OATP1A2 and OATP2B1. | 3.22e-05 | 2 | 198 | 2 | 38432624 | |
| Pubmed | Promoter Methylation and BDNF and DAT1 Gene Expression Profiles in Patients with Drug Addiction. | 3.22e-05 | 2 | 198 | 2 | 26160290 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 21143597 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 7535778 | ||
| Pubmed | TEAD3 inhibits the proliferation and metastasis of prostate cancer via suppressing ADRBK2. | 3.22e-05 | 2 | 198 | 2 | 36907139 | |
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 21176997 | ||
| Pubmed | 3.22e-05 | 2 | 198 | 2 | 23065263 | ||
| Pubmed | Impaired long-term memory and long-term potentiation in N-type Ca2+ channel-deficient mice. | 3.22e-05 | 2 | 198 | 2 | 16939638 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ABCB7 ACE KLHL9 SIMC1 RBM14 TAF2 SNX9 HSPA9 CNN2 BRWD1 ST7 CARMIL1 MAPRE1 PAN3 PC RPL7 | 3.38e-05 | 853 | 198 | 16 | 28718761 |
| Pubmed | RALGAPA1 DENND4A SLC35E1 CDKAL1 GLE1 PLXNA1 ST7 VPS8 GOSR2 ATF6 OCLN SEC63 | 3.57e-05 | 504 | 198 | 12 | 34432599 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 HSPA13 DOCK5 DLG1 HSPA9 PLXNA1 GPI SPTLC2 ST7 OPA3 GOSR2 SHTN1 P3H4 MAPRE1 RIF1 ATM WDFY3 PC | 4.03e-05 | 1061 | 198 | 18 | 33845483 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 HIVEP2 DOCK5 KLHL9 GRK3 ZNF608 ARHGAP44 ZNF638 DLG1 PLCG1 SNX9 ZNF449 AMD1 MAN2B2 ST7 CARMIL1 HECTD4 SHTN1 ATF6 PAN3 AADAT ZNF44 | 4.47e-05 | 1489 | 198 | 22 | 28611215 |
| Pubmed | SLC43A2 USP34 ABCB7 SPG7 BBS4 MAP3K3 ZBTB40 ZNF638 DLG1 PLCG1 TASOR BRWD1 DTL SLFN12 MAPRE1 SLC44A1 PAN3 SEC63 | 5.31e-05 | 1084 | 198 | 18 | 11544199 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 6.13e-05 | 118 | 198 | 6 | 19156168 | |
| Pubmed | 6.32e-05 | 14 | 198 | 3 | 32005751 | ||
| Pubmed | 6.63e-05 | 174 | 198 | 7 | 32149426 | ||
| Pubmed | USP34 ADK RBM14 TAF2 GPI MED20 USP28 POLE POLR3C MAPRE1 RIF1 POLR3B CSE1L ATM NHEJ1 SNRPA HDAC1 | 7.67e-05 | 1014 | 198 | 17 | 32416067 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 8.20e-05 | 180 | 198 | 7 | 30110629 | |
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 24058088 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 31298409 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 21795541 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 22087873 | ||
| Pubmed | Genotype distributions in top-level soccer players: a role for ACE? | 9.64e-05 | 3 | 198 | 2 | 19277943 | |
| Pubmed | Histone deacetylase regulation of ATM-mediated DNA damage signaling. | 9.64e-05 | 3 | 198 | 2 | 23939379 | |
| Pubmed | Leat-associated seizures the possible role of EAAT2, pyruvate carboxylase and glutamine synthetase. | 9.64e-05 | 3 | 198 | 2 | 38086219 | |
| Pubmed | BDNF/TrkB signaling augments smooth muscle cell proliferation in pulmonary hypertension. | 9.64e-05 | 3 | 198 | 2 | 23058367 | |
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 18363853 | ||
| Pubmed | SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. | 9.64e-05 | 3 | 198 | 2 | 23852118 | |
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 22082040 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 31365862 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 26873362 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 27551991 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 18644470 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 23042896 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 27417115 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 26676989 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 28975866 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 29030221 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 25762688 | ||
| Pubmed | BBS4 is necessary for ciliary localization of TrkB receptor and activation by BDNF. | 9.64e-05 | 3 | 198 | 2 | 24867303 | |
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 21491204 | ||
| Pubmed | The platelet-derived growth factor alpha-receptor is encoded by a growth-arrest-specific (gas) gene. | 9.64e-05 | 3 | 198 | 2 | 8643452 | |
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 35848503 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 29927735 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 19892410 | ||
| Pubmed | AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation. | 9.64e-05 | 3 | 198 | 2 | 33783988 | |
| Pubmed | ATM damage response and XLF repair factor are functionally redundant in joining DNA breaks. | 9.64e-05 | 3 | 198 | 2 | 21160472 | |
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 20560925 | ||
| Pubmed | 9.64e-05 | 3 | 198 | 2 | 17392738 | ||
| Pubmed | PARP-1, PARP-2 and ATM in the DNA damage response: functional synergy in mouse development. | 9.64e-05 | 3 | 198 | 2 | 15279798 | |
| Pubmed | ABCB7 HK1 SPART FDFT1 SNX9 HSPA9 SPTLC2 SHTN1 POLR3B CSE1L OCLN HDAC1 | 9.72e-05 | 560 | 198 | 12 | 35241646 | |
| Pubmed | 1.02e-04 | 397 | 198 | 10 | 21319273 | ||
| Pubmed | HK1 SPART RBM14 PLCG1 SNX9 HSPA9 POLR3C RIF1 PDIA6 CSE1L SEC63 SNRPA HDAC1 | 1.04e-04 | 653 | 198 | 13 | 33742100 | |
| Pubmed | USP34 HK1 ZNF638 UTP20 ASCC3 SNX9 HSPA9 POLE USP24 RIF1 CSE1L ATM RPL7 | 1.04e-04 | 653 | 198 | 13 | 22586326 | |
| Pubmed | 1.17e-04 | 17 | 198 | 3 | 20413850 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | GLE1 RBM14 UTP20 POLR1B ASCC3 TASOR POLE RIF1 POLR3B CSE1L DROSHA ELAVL2 RPL7 HDAC1 | 1.26e-04 | 759 | 198 | 14 | 35915203 |
| Pubmed | RALGAPA1 ABCB7 HK1 SPART CDKAL1 HSPA13 FDFT1 DLG1 ASCC3 HSPA9 ST7 POLE GOSR2 MAPRE1 ATF6 PDIA6 ATM CRYBG3 OCLN SEC63 RPL7 | 1.26e-04 | 1487 | 198 | 21 | 33957083 | |
| Pubmed | 1.29e-04 | 135 | 198 | 6 | 31405213 | ||
| Pubmed | Analyses of shared genetic factors between asthma and obesity in children. | 1.50e-04 | 47 | 198 | 4 | 20816195 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 CWF19L2 SPART PIP4K2A BUB1 RBM14 SNX9 USP28 DTL POLR3C DROSHA CRYBG3 | 1.53e-04 | 588 | 198 | 12 | 38580884 |
| Pubmed | 1.55e-04 | 418 | 198 | 10 | 34709266 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | USP34 CD300LB GLUL HSPA9 MUC16 CSE1L ADAM5 SLC13A5 RPL7 HDAC1 | 1.61e-04 | 420 | 198 | 10 | 28065597 |
| Pubmed | 1.92e-04 | 4 | 198 | 2 | 21849517 | ||
| GeneFamily | Solute carriers | SLC43A2 SLCO2B1 SLC6A17 SLC5A7 SLC35E1 UCP3 SLC26A5 SLC35F1 SLC6A3 SLC44A1 SLCO1A2 SLC6A20 SLC13A5 | 1.56e-05 | 395 | 143 | 13 | 752 |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 4.28e-04 | 19 | 143 | 3 | 832 | |
| GeneFamily | Olfactory receptors, family 8 | 6.03e-04 | 49 | 143 | 4 | 155 | |
| GeneFamily | RNA polymerase subunits | 1.52e-03 | 29 | 143 | 3 | 726 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | RALGAPA1 SPG7 ENPP2 BBS4 NME8 HSPA13 ADK EVI5 CYRIA GRK3 FDFT1 PIP4K2A GLUL CMKLR1 ASCC3 TASOR AMD1 PARP2 GOSR2 POLR3C PDIA6 CSE1L OXCT1 EGR1 EDEM2 ATM UEVLD | 3.83e-07 | 1215 | 195 | 27 | M41122 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | ADAD1 THNSL1 PIP4K2A BUB1 UTP20 POLR1B USP28 POLE PIWIL2 SHTN1 RIF1 POLR3B DROSHA ELAVL2 ATM | 1.88e-06 | 396 | 183 | 15 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 2.74e-05 | 101 | 183 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | THNSL1 BUB1 PRMT9 UTP20 REV1 USP28 POLE PIWIL2 RIF1 POLR3B DROSHA ATM | 3.38e-05 | 333 | 183 | 12 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | ENPP2 ABCA8 ELMO1 DOCK5 PTPRD PIP4K2A DLG1 SHTN1 SLC44A1 SLCO1A2 | 2.25e-08 | 200 | 197 | 10 | 26b989e30bbbaf30904ced03f6aae3dea25c732c |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | ENPP2 ABCA8 ELMO1 DOCK5 PTPRD PIP4K2A DLG1 SHTN1 SLC44A1 SLCO1A2 | 2.25e-08 | 200 | 197 | 10 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | ENPP2 ABCA8 ELMO1 DOCK5 PTPRD PIP4K2A DLG1 SHTN1 SLC44A1 SLCO1A2 | 2.25e-08 | 200 | 197 | 10 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | ENPP2 ABCA8 ELMO1 DOCK5 PTPRD PIP4K2A DLG1 SHTN1 SLC44A1 SLCO1A2 | 2.25e-08 | 200 | 197 | 10 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | ENPP2 ABCA8 ELMO1 DOCK5 PTPRD PIP4K2A DLG1 SHTN1 SLC44A1 SLCO1A2 | 2.25e-08 | 200 | 197 | 10 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | ENPP2 ABCA8 ELMO1 DOCK5 PTPRD PIP4K2A DLG1 SHTN1 SLC44A1 SLCO1A2 | 2.25e-08 | 200 | 197 | 10 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-07 | 193 | 197 | 9 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.59e-07 | 198 | 197 | 9 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-07 | 198 | 197 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | NKX6-2 ENPP2 ABCA8 DOCK5 PTPRD PIP4K2A SHTN1 SLC44A1 SLCO1A2 | 2.70e-07 | 199 | 197 | 9 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | NKX6-2 ENPP2 ABCA8 DOCK5 PTPRD PIP4K2A SHTN1 SLC44A1 SLCO1A2 | 2.82e-07 | 200 | 197 | 9 | acdef0b9096c774040948fc75621ff2b08ea2ee8 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | NKX6-2 ENPP2 ABCA8 DOCK5 PTPRD PIP4K2A SHTN1 SLC44A1 SLCO1A2 | 2.82e-07 | 200 | 197 | 9 | 091a18d6efed81cab99955c3047f172170f70476 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | NKX6-2 ENPP2 ABCA8 DOCK5 PTPRD PIP4K2A SHTN1 SLC44A1 SLCO1A2 | 2.82e-07 | 200 | 197 | 9 | 3b8513defe25262ab4b492345b2628570eaefd17 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.95e-07 | 169 | 197 | 8 | c8691c4f707d46b2865fe46eabe24ea4d03c7b43 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 183 | 197 | 8 | ffb1bbbccb34d1a7e99872611f497450039d5019 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 184 | 197 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 184 | 197 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 184 | 197 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-06 | 185 | 197 | 8 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-06 | 186 | 197 | 8 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-06 | 186 | 197 | 8 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-06 | 189 | 197 | 8 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 192 | 197 | 8 | 86d792682ba51696f503c79625dd20f87bcf651f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.33e-06 | 192 | 197 | 8 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 192 | 197 | 8 | d0ad6a205ad50a3c523fa68676996b289eabc5de | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 193 | 197 | 8 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 193 | 197 | 8 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 193 | 197 | 8 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 193 | 197 | 8 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 193 | 197 | 8 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.42e-06 | 193 | 197 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 2.42e-06 | 193 | 197 | 8 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.51e-06 | 194 | 197 | 8 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 194 | 197 | 8 | 0866ab6792cee274a71991d5c37a37f574ff446e | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.61e-06 | 195 | 197 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.61e-06 | 195 | 197 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 196 | 197 | 8 | 4370473693d2dd4a8c451a4c477eb79baa33ae12 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.71e-06 | 196 | 197 | 8 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 197 | 197 | 8 | 7b12f9d4ad1e84df58e86591a491c84d4f36eac5 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.93e-06 | 198 | 197 | 8 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.93e-06 | 198 | 197 | 8 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-06 | 198 | 197 | 8 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 2.93e-06 | 198 | 197 | 8 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.04e-06 | 199 | 197 | 8 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.04e-06 | 199 | 197 | 8 | 0f3ce61bbae69f7e333ed8dacf7257645624e163 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 3.04e-06 | 199 | 197 | 8 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | mLN-Mast_cell|mLN / Region, Cell class and subclass | 3.15e-06 | 200 | 197 | 8 | 9a5f1d99d8d160923d4d0fbbf9ad48a26f8a4fad | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-06 | 200 | 197 | 8 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | mLN-(7)_Mast_cell-(70)_Mast|mLN / shred on region, Cell_type, and subtype | 3.15e-06 | 200 | 197 | 8 | a6c258cae678be581b1d85cf3446c65c34b13499 | |
| ToppCell | mLN-(7)_Mast_cell|mLN / shred on region, Cell_type, and subtype | 3.15e-06 | 200 | 197 | 8 | 13bca944fbdbc0be6687eca82c62a4d231ab94f0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-06 | 200 | 197 | 8 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | mLN-Mast_cell-Mast|mLN / Region, Cell class and subclass | 3.15e-06 | 200 | 197 | 8 | 81ea6e7a3940277751faf9097b30198159998c7b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-06 | 200 | 197 | 8 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.15e-06 | 200 | 197 | 8 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-06 | 200 | 197 | 8 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 145 | 197 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 1.05e-05 | 169 | 197 | 7 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 171 | 197 | 7 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 171 | 197 | 7 | 355a27ea88410a84210f7e4298c7c4f90cf2f8a9 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-05 | 172 | 197 | 7 | eba1568d4307e91c94fc616549057cbed8df5840 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-05 | 183 | 197 | 7 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-05 | 183 | 197 | 7 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-05 | 184 | 197 | 7 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-05 | 184 | 197 | 7 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-05 | 185 | 197 | 7 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.95e-05 | 186 | 197 | 7 | 05c40bac5c0ade8b67b7c2112739466e02dbf22b | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-05 | 186 | 197 | 7 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-05 | 187 | 197 | 7 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-05 | 187 | 197 | 7 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-05 | 188 | 197 | 7 | d9692b6048d9b85524a07a1807bdd4757731c151 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-05 | 188 | 197 | 7 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 189 | 197 | 7 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 189 | 197 | 7 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 189 | 197 | 7 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 189 | 197 | 7 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 189 | 197 | 7 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.31e-05 | 191 | 197 | 7 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.38e-05 | 129 | 197 | 6 | b3cb0c10659d1216b8f7de3aa1f9aac101cb65dd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 193 | 197 | 7 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.47e-05 | 193 | 197 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 2.47e-05 | 193 | 197 | 7 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.56e-05 | 194 | 197 | 7 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.56e-05 | 194 | 197 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 195 | 197 | 7 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | ILEUM-non-inflamed-(3)_moDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.73e-05 | 196 | 197 | 7 | e10f01172fd076d6892906853f9375d4c3058951 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.73e-05 | 196 | 197 | 7 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 196 | 197 | 7 | f068ce40bf35021baf1468ae9ce30a92162eb14d | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-05 | 196 | 197 | 7 | fe90501010128b72e6711c567cb04b012f1520a4 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.73e-05 | 196 | 197 | 7 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.82e-05 | 197 | 197 | 7 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 2.82e-05 | 197 | 197 | 7 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 197 | 197 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class | 2.82e-05 | 197 | 197 | 7 | 344801997b89bd81d8d5c3c872934de523233a8d | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 2.91e-05 | 198 | 197 | 7 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | 2.91e-05 | 198 | 197 | 7 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-05 | 198 | 197 | 7 | 06201b34d3e38f22c93b759511f7b376504bac06 | |
| ToppCell | Monocytes|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.91e-05 | 198 | 197 | 7 | 8beccf03c9ec9cd02a96107a9d7ca9a6764c6a61 | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.91e-05 | 198 | 197 | 7 | 1ca91559fef231896e16180f5e050155c38f7cfa | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 199 | 197 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-05 | 199 | 197 | 7 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| Drug | C768-0445; Down 200; 10uM; MCF7; HT_HG-U133A_EA | ACTR5 SLC35E1 KLHL9 GLE1 UTP20 POLR1B TASOR HSPA9 AMD1 NCKIPSD GOSR2 | 9.65e-07 | 193 | 196 | 11 | 865_DN |
| Disease | Schizophrenia | HK1 ACE BDNF CHRNB2 ADK PIP4K2A GLUL DLG1 ALDH1A1 HSPA9 CACNA1B CACNA1F GRM7 SLC6A3 PLA2G4B EDEM2 OR4C46 ELAVL2 ATM HCRTR1 HDAC1 RASD2 | 6.19e-08 | 883 | 189 | 22 | C0036341 |
| Disease | Attention Deficit Disorder | 1.09e-05 | 22 | 189 | 4 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.09e-05 | 22 | 189 | 4 | C1321905 | |
| Disease | Attention deficit hyperactivity disorder | 1.57e-05 | 24 | 189 | 4 | C1263846 | |
| Disease | Intellectual Disability | RALGAPA1 HIVEP2 HK1 BDNF ADK FDFT1 ZBTB40 TAF2 ASCC3 CACNA1B SLC6A3 POLR3B | 3.43e-05 | 447 | 189 | 12 | C3714756 |
| Disease | germ cell cancer (implicated_via_orthology) | 4.08e-05 | 2 | 189 | 2 | DOID:2994 (implicated_via_orthology) | |
| Disease | anemia (is_implicated_in) | 8.94e-05 | 14 | 189 | 3 | DOID:2355 (is_implicated_in) | |
| Disease | Mood Disorders | 1.10e-04 | 168 | 189 | 7 | C0525045 | |
| Disease | Body Weight | 1.11e-04 | 15 | 189 | 3 | C0005910 | |
| Disease | sarcopenia | 2.72e-04 | 20 | 189 | 3 | EFO_1000653 | |
| Disease | Profound Mental Retardation | 2.83e-04 | 139 | 189 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.83e-04 | 139 | 189 | 6 | C0025363 | |
| Disease | Mental deficiency | 2.83e-04 | 139 | 189 | 6 | C0917816 | |
| Disease | C-reactive protein measurement | USP34 CWF19L2 OR5T1 GLS2 RPS6KA1 BDNF CHRNB2 ZNF608 FDFT1 ZBTB40 POLR1B FTO ARHGEF28 CARMIL1 OPA3 OR8J1 SERPINA10 RPL7 HCRTR1 | 2.90e-04 | 1206 | 189 | 19 | EFO_0004458 |
| Disease | obesity (is_implicated_in) | 3.04e-04 | 91 | 189 | 5 | DOID:9970 (is_implicated_in) | |
| Disease | congenital nonspherocytic hemolytic anemia (is_implicated_in) | 4.03e-04 | 5 | 189 | 2 | DOID:2861 (is_implicated_in) | |
| Disease | connective tissue disease (is_implicated_in) | 4.03e-04 | 5 | 189 | 2 | DOID:65 (is_implicated_in) | |
| Disease | body weight | RALGAPA1 HIVEP2 BDNF CDKAL1 PIP4K2A ZNF638 FTO PLXNA1 GPR151 CACNA1B CWH43 DTL HECTD4 SHTN1 PRDM5 GRM7 RFX3 EGR1 ELAVL2 | 5.02e-04 | 1261 | 189 | 19 | EFO_0004338 |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 5.07e-04 | 216 | 189 | 7 | EFO_0007925, EFO_0007927 | |
| Disease | 3-hydroxybutyrate measurement | 5.36e-04 | 25 | 189 | 3 | EFO_0010982 | |
| Disease | Depressive disorder | 5.80e-04 | 289 | 189 | 8 | C0011581 | |
| Disease | normal | 6.02e-04 | 6 | 189 | 2 | PATO_0000461 | |
| Disease | peptide measurement | 6.97e-04 | 109 | 189 | 5 | EFO_0010520 | |
| Disease | coronary artery disease | CWF19L2 HIVEP2 GLS2 RPS6KA1 ABCA8 BDNF DOCK5 GRK3 PLCB2 PLCG1 FTO DHX58 CARMIL1 HECTD4 SLC35F1 GOSR2 EDEM2 SEC63 | 7.03e-04 | 1194 | 189 | 18 | EFO_0001645 |
| Disease | Subwakefullness Syndrome | 8.39e-04 | 7 | 189 | 2 | C0751511 | |
| Disease | Sleep-Related Neurogenic Tachypnea | 8.39e-04 | 7 | 189 | 2 | C0751510 | |
| Disease | Short Sleeper Syndrome | 8.39e-04 | 7 | 189 | 2 | C0751509 | |
| Disease | Long Sleeper Syndrome | 8.39e-04 | 7 | 189 | 2 | C0751508 | |
| Disease | Sleep Wake Disorders | 8.39e-04 | 7 | 189 | 2 | C4042891 | |
| Disease | Sleep Disorders | 8.39e-04 | 7 | 189 | 2 | C0851578 | |
| Disease | able to hear with hearing aids | 8.39e-04 | 7 | 189 | 2 | EFO_0009720 | |
| Disease | breast carcinoma (is_marker_for) | 8.62e-04 | 66 | 189 | 4 | DOID:3459 (is_marker_for) | |
| Disease | monocyte count | RALGAPA1 ZNF777 DENND4A CHRNB2 CDKAL1 EVI5 OR2K2 CYRIA ZNF608 FDFT1 POLR1B CMKLR1 CNN2 ANK1 CARMIL1 ATF6 SLCO1A2 ATM PAN3 | 8.67e-04 | 1320 | 189 | 19 | EFO_0005091 |
| Disease | hearing loss | 9.12e-04 | 67 | 189 | 4 | EFO_0004238 | |
| Disease | Cocaine-Related Disorders | 9.60e-04 | 117 | 189 | 5 | C0236736 | |
| Disease | insulin sensitivity measurement, insulin response measurement | 1.11e-03 | 8 | 189 | 2 | EFO_0004471, EFO_0008473 | |
| Disease | age at initiation of corrective lens use | 1.11e-03 | 8 | 189 | 2 | EFO_0021781 | |
| Disease | Hypoxemia | 1.22e-03 | 33 | 189 | 3 | C0700292 | |
| Disease | Hypoxia | 1.22e-03 | 33 | 189 | 3 | C0242184 | |
| Disease | Anoxemia | 1.22e-03 | 33 | 189 | 3 | C0003129 | |
| Disease | Anoxia | 1.22e-03 | 33 | 189 | 3 | C0003130 | |
| Disease | heart failure | 1.27e-03 | 185 | 189 | 6 | EFO_0003144 | |
| Disease | Mental Depression | 1.31e-03 | 254 | 189 | 7 | C0011570 | |
| Disease | Cocaine Abuse | 1.38e-03 | 127 | 189 | 5 | C0009171 | |
| Disease | behavioural disinhibition measurement | 1.39e-03 | 75 | 189 | 4 | EFO_0006946 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.40e-03 | 257 | 189 | 7 | DOID:10652 (is_marker_for) | |
| Disease | Sideroblastic anemia | 1.43e-03 | 9 | 189 | 2 | C0002896 | |
| Disease | Chronic schizophrenia | 1.43e-03 | 9 | 189 | 2 | C0221765 | |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 1.43e-03 | 9 | 189 | 2 | EFO_0800517 | |
| Disease | insulin response measurement | 1.43e-03 | 9 | 189 | 2 | EFO_0008473 | |
| Disease | Burkitt Lymphoma | 1.58e-03 | 36 | 189 | 3 | C0006413 | |
| Disease | Lung diseases | 1.61e-03 | 78 | 189 | 4 | C0024115 | |
| Disease | R-warfarin measurement | 1.66e-03 | 265 | 189 | 7 | EFO_0803324 | |
| Disease | Liver carcinoma | 1.68e-03 | 507 | 189 | 10 | C2239176 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.76e-03 | 80 | 189 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.76e-03 | 80 | 189 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 1.77e-03 | 268 | 189 | 7 | C0001973 | |
| Disease | forced expiratory volume | ENPP2 RPS6KA1 DENND2D CHRNB2 ZBTB40 PDE11A ANK1 CARMIL1 PRDM5 CSE1L DROSHA SLCO1A2 PC | 1.81e-03 | 789 | 189 | 13 | EFO_0004314 |
| Disease | Cocaine Dependence | 2.06e-03 | 139 | 189 | 5 | C0600427 | |
| Disease | Inherited neuropathies | 2.15e-03 | 40 | 189 | 3 | C0598589 | |
| Disease | interleukin-6 measurement, response to stimulus | 2.16e-03 | 11 | 189 | 2 | EFO_0004810, GO_0050896 | |
| Disease | obstructive sleep apnea (is_implicated_in) | 2.16e-03 | 11 | 189 | 2 | DOID:0050848 (is_implicated_in) | |
| Disease | cognitive function measurement | USP34 DENND4A ABCA8 CYRIA PTPRD ZNF608 ZNF638 ALDH1A1 TAF2 REV1 VPS8 NCKIPSD PRDM5 GRM7 STRIP1 PDIA6 CSE1L ELAVL2 HCRTR1 | 2.24e-03 | 1434 | 189 | 19 | EFO_0008354 |
| Disease | urate measurement, bone density | ACTR5 ABCA8 CDKAL1 DOCK5 PTPRD FTO DNAH9 CARMIL1 SLC26A5 ELAVL2 SEL1L2 | 2.26e-03 | 619 | 189 | 11 | EFO_0003923, EFO_0004531 |
| Disease | non-high density lipoprotein cholesterol measurement | USP34 HK1 DTX3L CDKAL1 EVI5 FDFT1 ASCC3 BRWD1 CARMIL1 VN1R1 P3H4 CSE1L | 2.27e-03 | 713 | 189 | 12 | EFO_0005689 |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 2.58e-03 | 12 | 189 | 2 | C1861063 | |
| Disease | vital capacity | USP34 HIVEP2 ENPP2 RPS6KA1 BDNF PTPRD ZBTB40 DLG1 PLXNA1 PDE11A PCDHA10 PIWIL2 SHTN1 PRDM5 GRM7 CSE1L PC | 2.60e-03 | 1236 | 189 | 17 | EFO_0004312 |
| Disease | age at diagnosis, osteonecrosis | 2.82e-03 | 44 | 189 | 3 | EFO_0004259, EFO_0004918 | |
| Disease | body surface area | RALGAPA1 ENPP2 BDNF MAP3K3 DOCK5 ZNF608 FTO TASOR PDE11A DTL SHTN1 | 3.03e-03 | 643 | 189 | 11 | EFO_0022196 |
| Disease | Fetal Alcohol Spectrum Disorders | 3.04e-03 | 13 | 189 | 2 | C2985290 | |
| Disease | Creutzfeldt-Jakob Disease, Familial | 3.04e-03 | 13 | 189 | 2 | C0751254 | |
| Disease | Creutzfeldt-Jakob disease | 3.04e-03 | 13 | 189 | 2 | C0022336 | |
| Disease | intermediate coronary syndrome (is_marker_for) | 3.04e-03 | 13 | 189 | 2 | DOID:8805 (is_marker_for) | |
| Disease | New Variant Creutzfeldt-Jakob Disease | 3.04e-03 | 13 | 189 | 2 | C0376329 | |
| Disease | leukemia (is_implicated_in) | 3.04e-03 | 13 | 189 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | reticulocyte count | SLC43A2 USP34 DENND4A HK1 GLS2 RPS6KA1 DENND2D DOCK5 FDFT1 ZBTB40 TAF2 ARHGEF28 ANK1 HECTD4 HCRTR1 | 3.11e-03 | 1045 | 189 | 15 | EFO_0007986 |
| Disease | lean body mass | 3.20e-03 | 379 | 189 | 8 | EFO_0004995 | |
| Disease | reticulocyte measurement | SLC43A2 USP34 DENND4A HK1 GLS2 DENND2D CDKAL1 DOCK5 OR2K2 FDFT1 ZBTB40 ARHGEF28 ANK1 HECTD4 HCRTR1 | 3.34e-03 | 1053 | 189 | 15 | EFO_0010700 |
| Disease | myocarditis (implicated_via_orthology) | 3.53e-03 | 14 | 189 | 2 | DOID:820 (implicated_via_orthology) | |
| Disease | Adenocarcinoma Of Esophagus | 3.53e-03 | 14 | 189 | 2 | C0279628 | |
| Disease | diabetic neuropathy (is_implicated_in) | 3.53e-03 | 14 | 189 | 2 | DOID:9743 (is_implicated_in) | |
| Disease | Birth Weight | 3.53e-03 | 14 | 189 | 2 | C0005612 | |
| Disease | glutamine measurement | 3.55e-03 | 97 | 189 | 4 | EFO_0009768 | |
| Disease | neuroticism measurement, cognitive function measurement | PIP4K2A ZNF638 ASCC3 FTO PCDHA10 SHTN1 GRM7 PDIA6 CSE1L ELAVL2 | 3.70e-03 | 566 | 189 | 10 | EFO_0007660, EFO_0008354 |
| Disease | Bipolar Disorder | 3.79e-03 | 477 | 189 | 9 | C0005586 | |
| Disease | Acute Confusional Senile Dementia | 3.82e-03 | 99 | 189 | 4 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 3.82e-03 | 99 | 189 | 4 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 3.82e-03 | 99 | 189 | 4 | C0750901 | |
| Disease | Presenile dementia | 3.82e-03 | 99 | 189 | 4 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 3.82e-03 | 99 | 189 | 4 | C0494463 | |
| Disease | multiple sclerosis (is_marker_for) | 3.84e-03 | 49 | 189 | 3 | DOID:2377 (is_marker_for) | |
| Disease | Familial Alzheimer Disease (FAD) | 3.96e-03 | 100 | 189 | 4 | C0276496 | |
| Disease | Opioid use measurement | 4.06e-03 | 15 | 189 | 2 | EFO_0009937 | |
| Disease | infant head circumference | 4.06e-03 | 15 | 189 | 2 | EFO_0004577 | |
| Disease | hepcidin:transferrin saturation ratio | 4.06e-03 | 15 | 189 | 2 | EFO_0007902 | |
| Disease | Alzheimer's Disease | 4.11e-03 | 101 | 189 | 4 | C0002395 | |
| Disease | pancreatic cancer (is_marker_for) | 4.11e-03 | 101 | 189 | 4 | DOID:1793 (is_marker_for) | |
| Disease | Orofacial cleft | 4.30e-03 | 51 | 189 | 3 | HP_0000202 | |
| Disease | Benign neoplasm of stomach | 5.21e-03 | 17 | 189 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.21e-03 | 17 | 189 | 2 | C0496905 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MNITYMSPAKLGEDI | 86 | Q9NPJ3 | |
| AQRFATRGYPMEDMK | 501 | A9YTQ3 | |
| EMMKRALQYSPSAGI | 66 | Q8N5Z0 | |
| KMGVLMLPGNAFYVD | 376 | Q8N5Z0 | |
| INFQPKMGELYMLLA | 331 | Q96RK4 | |
| KMGELYMLLAVALTN | 336 | Q96RK4 | |
| MQLKNISYGIEPMEA | 86 | Q6NVV9 | |
| MHGYMLKLGNPFLTQ | 561 | P35626 | |
| PGMLALDNMLYFAKH | 376 | Q92556 | |
| SLMKVMPYVDILFGN | 226 | P55263 | |
| IPYHEGFKMAMSKVL | 531 | Q6P2P2 | |
| EALGFIMNMFQAPTL | 466 | O43683 | |
| LTMVISYFGCMKAAP | 6 | P23560 | |
| EPKANVFKMGEVYQM | 1586 | Q68DQ2 | |
| NMSASAMLSYFKPLL | 1191 | P12821 | |
| MKYPLMPLVNDLTFS | 1 | Q0VDE8 | |
| YPNETFEMNKLGAMF | 2176 | Q86UK0 | |
| VPYMAKFVIFAKMND | 1236 | P16157 | |
| KVAKPTSMYMNDGYA | 401 | Q12959 | |
| LLLATMESMNGGKLY | 101 | P00352 | |
| LFYSKNPAMMEKSIF | 291 | Q96M93 | |
| PTFKEGMALEDYQRM | 536 | Q53GS7 | |
| GKMLENIFMPVFEAT | 476 | P23109 | |
| AFIILNYGPMSMLEQ | 386 | P18850 | |
| QMMSELLFECYGIPK | 146 | Q9H9F9 | |
| YMFNMTGLKTSPVAI | 296 | Q9NZJ0 | |
| PDEMTVGKVYAALMI | 1846 | Q00975 | |
| FYMETQSMLVVPKGE | 751 | Q06278 | |
| IKMNDVYGPMSQILE | 1771 | Q7Z401 | |
| LFAPYGTVMSCAVMK | 21 | Q96PK6 | |
| AFFPDMVNMVVLGKY | 581 | Q9ULC6 | |
| ESLMLFKGPLAMKQY | 251 | Q96DM1 | |
| YTDPRAAKGFMLAMA | 131 | Q16625 | |
| MLGMYVPDRFSLKSS | 1 | Q9NQX1 | |
| KVPGKYDMLQMDYAT | 196 | Q9UGN5 | |
| SEAPLYGQMMIYAKF | 6 | Q8N1W1 | |
| YPGMMVDSTFYNKIK | 896 | P16234 | |
| YAVIGMQMFGKVALQ | 1341 | O60840 | |
| RYMADMGQPGSLKFN | 13936 | Q8WXI7 | |
| DKMASVFYTLVIPML | 271 | Q8NH50 | |
| MSLFYAEATPMLKTL | 186 | Q9H0Q0 | |
| GKMVSLFYGIIAPML | 271 | P58173 | |
| VKFYIPDMNSRMAGQ | 81 | O76036 | |
| FGMKGFIMINPLEYK | 96 | Q8TAT5 | |
| EFVKSFNLPMLMLGG | 286 | Q13547 | |
| VTLLNFMDPQKMPYL | 201 | Q9C0B1 | |
| YMGAMNNILKFLVSG | 341 | Q8N370 | |
| NILFMMFGYDPKNLN | 226 | Q5W064 | |
| MFGYDPKNLNMSRLD | 231 | Q5W064 | |
| EVFPIMAKEGQLYAM | 196 | Q9Y5P6 | |
| MDATNMPAVKAIIYQ | 326 | P37268 | |
| NYPKLEEMMLLSNGA | 31 | P18146 | |
| QMYKGTVSMPVFQSL | 301 | Q9BV94 | |
| AKMPAISDQDMSAYL | 1821 | Q9UIW2 | |
| MVVGAFPMAKLLYLG | 1 | Q9H6K4 | |
| DKAVAIFYTMITPML | 266 | A6NHA9 | |
| AMMANAYLFFPPVVN | 276 | Q9H342 | |
| MAMSFDRYIAICKPL | 116 | Q8NGD2 | |
| EKVMQMYLPFCGIAI | 356 | Q9HCR9 | |
| EVGDMAPIYFKKAIM | 776 | Q2TBE0 | |
| KPSMAELGLCMYQFE | 281 | O60447 | |
| DYAAKLMKNIRFPLM | 231 | Q9P2J3 | |
| KLTPFMLGALVAMYE | 481 | P06744 | |
| KGVDMMAALDLYFQL | 336 | Q9UI32 | |
| AFQDKYFMIGGMLLT | 186 | O14653 | |
| SYPGAMLNIMVKEGF | 891 | Q07864 | |
| FGSEFFMGQLMKRLP | 476 | P0C869 | |
| QLMGLLPGLASAMKY | 746 | Q5JZY3 | |
| FMIKLPQYSSLEIML | 3966 | Q9Y4D8 | |
| DKMASVFYTLVIPML | 271 | Q8NGG0 | |
| MARMARKAGNFYVPA | 71 | P18124 | |
| QLFEKMVSGMYLGEL | 291 | P19367 | |
| VPAVAEEFMSMFGKL | 191 | Q8TDV0 | |
| EEFMSMFGKLYPLLA | 196 | Q8TDV0 | |
| YSPSQIGAFVLMKMK | 161 | P38646 | |
| QGMPEVYNFDFITMK | 531 | Q6P4A8 | |
| AIIDMSYASNNVPKM | 66 | Q6IF42 | |
| GINKEMMYSFSSLVP | 271 | Q9Y5I2 | |
| PNGEYMFMRAVNTAK | 176 | Q9Y6W8 | |
| MPMIGARFYTQLDAA | 746 | Q58A45 | |
| TFLEVKMEDYGLPFM | 301 | Q9HB29 | |
| APLGLMAMAYFQIFR | 226 | O43613 | |
| DDKMASVFYTLVIPM | 271 | Q8NGP2 | |
| MSGLPSDMDLYKLQL | 1 | Q8NG75 | |
| FLPLMYQLAARMGTK | 2516 | Q13315 | |
| DAKFYLTLPGTKMEM | 581 | Q9H7D0 | |
| FPLFMNGISKELEMK | 1911 | P17927 | |
| KALFRTVAMMVPDYA | 1546 | Q8TD57 | |
| FVKIPVKLFAANYMM | 361 | Q8TDB6 | |
| MYNSKGTGFLQLMPA | 96 | A2CJ06 | |
| KNPAFMGKMVEVDIY | 466 | Q5VV42 | |
| PMSTYLKMFAASLLA | 6 | Q69YU5 | |
| PAVMDQFYMKDGVTA | 186 | P17707 | |
| VLYMSSLLPAKMFAI | 441 | Q92819 | |
| MPELSRKFGTQMYEQ | 246 | Q96C10 | |
| LQFSPMAKGSQRYMV | 276 | Q9NSI6 | |
| NLLNMAYGVKRFSPM | 241 | Q12926 | |
| QFMDMLFPGSIALKK | 46 | Q15691 | |
| YPMVQSAFMEDGKSR | 756 | Q9Y2E5 | |
| LSASVALGMLYMPKV | 831 | Q14831 | |
| SPGREFYMDKVLMEF | 611 | Q8WWI5 | |
| FMPIPMYDASQALKT | 631 | Q5VZK9 | |
| KEMAEAYLGMPVANA | 156 | P48723 | |
| ITFYMPVDNLGMAVI | 131 | P38567 | |
| PEMPMFLGLAFATQY | 681 | Q8NFI3 | |
| GNKKLIYFIDDMNMP | 2536 | Q9NYC9 | |
| MPDVYFVNMAVAGLV | 61 | Q96CH1 | |
| MLSMLFNQFPGFKEV | 166 | P08579 | |
| QYMKDTNMLFLGGLI | 81 | Q86YT5 | |
| EAKYDAFLVTNMVPM | 691 | Q13822 | |
| MAVIYPFMQGLREAA | 181 | Q9H6A0 | |
| QIPVMLMPDDFKAYS | 56 | P48426 | |
| IFMEYMPGGSVKDQL | 441 | Q99759 | |
| YPAMAAINARKMKFA | 356 | Q15084 | |
| SAMPFKILYDDGKMV | 1046 | P23468 | |
| PADTMVQYMELFNKI | 186 | Q9H944 | |
| DKFMALVYAGQTPML | 271 | Q8NGS4 | |
| KTPMYLFLGNLSFMD | 56 | Q8NGT1 | |
| ASGTMVYGLFMLQKK | 316 | P41218 | |
| DKNMALFYGILTPML | 266 | Q8NH37 | |
| NPGKTMTIAMIFYLL | 311 | Q9H720 | |
| VYMSLPQGEKVQAMY | 16 | P15104 | |
| MRSKGYVTMLDPFQQ | 106 | Q9GZV3 | |
| SMAIEKYPLVFSPQM | 461 | O75691 | |
| EMGAAMDALEKYNFP | 1321 | Q9NRR4 | |
| MATKARVMYDFAAEP | 1 | Q9Y5X1 | |
| VYVGTGEKNMDLPFM | 261 | Q9H1X1 | |
| NMAEMKTSLFPYALQ | 21 | Q9C056 | |
| VMMQALKPYEGRPSF | 576 | P48380 | |
| MKLVGRNFYDPTSAM | 336 | Q8TC59 | |
| NATFAKVMMLVYPEE | 936 | Q5UIP0 | |
| AGSANAMAFIGKMYL | 331 | Q5TEA6 | |
| AMAFIGKMYLEGNAA | 336 | Q5TEA6 | |
| SYFLQKTMPVAMALL | 746 | Q6P1X5 | |
| VNLKGMFMQFSDLPF | 446 | P58743 | |
| GFLSAAEMPLFKLYM | 251 | Q9NPR9 | |
| LYNNEPFAIMLFGMV | 256 | Q5VSL9 | |
| NKIAEMMFGFVLDIP | 686 | Q8NDZ2 | |
| SMLYMAKLGPDVITE | 101 | A0MZ66 | |
| DGKPFVMNLQDLYMA | 206 | Q9H9Q4 | |
| IDKMASVFYTLLIPM | 276 | Q8NGG5 | |
| YNRGMNEFISPMEKL | 686 | Q8N3P4 | |
| AFVNMISFMPKYLEQ | 331 | P46721 | |
| LTMLGAMQVSKYGDL | 396 | P55809 | |
| GMMTAILGVFLYNKT | 321 | Q96K37 | |
| RIAYSMVKQFGMAPG | 656 | Q9UQ90 | |
| FPELMGVFAKAMIDI | 536 | Q9NRC1 | |
| PLSVATDNMMLEFYK | 491 | Q17R89 | |
| TNGLMYMFTPKIEQL | 221 | Q9NP91 | |
| LILAMVFSMGEAVPY | 506 | Q9NZQ3 | |
| SPMEENPAYSKLVMF | 156 | P59095 | |
| NPAYSKLVMFVQTEM | 161 | P59095 | |
| IYDPMGVKSLESMLN | 251 | Q9UK61 | |
| SLDVPLVGKYLMFTM | 291 | P17787 | |
| MAGFCPLLVEYTMVK | 871 | O94911 | |
| FLGGAKAMNIVVPFM | 146 | O75027 | |
| VAPMKALAAEMTDYF | 536 | Q8N3C0 | |
| VLPMLLTGMFSLFYK | 186 | H7C241 | |
| PIYMNFSEPLTKDMA | 186 | A8K4G0 | |
| MNPILYVFMGQDFKK | 311 | Q99788 | |
| FIKAMVSYGMNPVDL | 91 | Q99439 | |
| ACMFGLYSFMPVVIK | 291 | Q5T1Q4 | |
| KMSPLDMKDGFLAFQ | 51 | Q9Y5R8 | |
| FINLRSMMISAEYPK | 171 | I1YAP6 | |
| GQYFSPLDCMIKMVA | 251 | P55916 | |
| LKCTAGAYMFPDTML | 286 | Q8N0X7 | |
| LQEIFDGIQPKMFGM | 806 | P55060 | |
| LYMMLPVFNRVFGNA | 51 | Q8IZQ1 | |
| SVYDGKYLPAANMMA | 781 | Q7RTX1 | |
| KYLPAANMMAGLSSL | 786 | Q7RTX1 | |
| FGDVLIVIYPMKNHM | 1926 | Q6GYQ0 | |
| YKMLSENFMSLQEIP | 396 | Q9BUI4 | |
| YKDLLEMLSVGPSMV | 506 | Q8N427 | |
| LQYMTMAKLQKEFGP | 671 | Q9UBZ9 | |
| MAAGMAIFLPKFLER | 386 | O94956 | |
| LMLYMPAKIGAFGRE | 471 | O15270 | |
| AASYMLFDPKDSVMQ | 316 | Q92791 | |
| LPEKYMMNSVLENFT | 381 | Q99594 | |
| MPLFYMELALGQFNR | 111 | Q01959 | |
| MVLFFKGIPQTMAAF | 96 | Q9GZP7 | |
| MYSAQKTMDLPFLEA | 221 | P19174 | |
| RVKEMDAYGMVSPFA | 221 | Q96D21 | |
| FGNILAAVYAKMMGI | 511 | Q8IYQ7 | |
| MAVLGSFPYVTMDIK | 436 | Q9UGP8 | |
| VCVMTKIFYLSPEGM | 491 | Q8IYM2 | |
| RYTNQTFDKVMGPML | 781 | Q9NW08 | |
| LFALMMGSNRKFVDP | 221 | Q96RU2 | |
| TMPALFIFLEMKDYI | 791 | Q00722 | |
| PYQGNATMLVVLMEK | 291 | Q9UK55 | |
| MPEDVKNFYLMTNGF | 61 | Q68CL5 | |
| MSEGKPYLLEVMFAL | 2391 | Q9UPU5 | |
| MIAKFQEELPMYSLS | 131 | Q8IX04 | |
| GLYMDQKSLMATSPA | 1086 | Q9ULD9 | |
| KFMQELTEMLGFRPY | 551 | Q9H1V8 | |
| LDVLMKFSTNAYMPL | 671 | Q13395 | |
| GFKDMQMVFVSLGAP | 1301 | Q70CQ2 | |
| NPFFKLLTMLMEFAG | 2601 | Q70CQ2 | |
| MGKQTMGFPLLTYQD | 691 | Q9H9Y6 | |
| YAISKPDLMSQMERG | 326 | Q9ULD5 | |
| VGIMASDYDPKLQMQ | 721 | P31629 | |
| VFDSLNYLPNMLLGM | 676 | P11498 | |
| YPKMLEAANLMEGLV | 11 | P15621 | |
| ELMLSMLFNQFPGFK | 221 | P09012 | |
| MVKFYTCFPVLMDGN | 956 | Q14966 | |
| KMETMYPFIVTLEGN | 241 | Q6P9G9 | |
| FALLLEMMYTGKLPV | 71 | Q9NUA8 | |
| LMFEMLTGSLPFQGK | 251 | Q15418 |